Scinai Immunotherapeutics Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $9,715,000.
Profit Margin
| 2014 | 0 | -1.99M | |
|---|---|---|---|
| 2015 | 0 | -2.61M | |
| 2016 | 0 | -9.18M | |
| 2017 | 0 | -9.92M | |
| 2018 | 0 | -23.29M | |
| 2019 | 0 | -109.19M | |
| 2020 | 0 | -1.38M | |
| 2021 | 0 | -39.97M | |
| 2022 | 0 | -5.79M | |
| 2023 | 0 | -6.5M |
SCNI Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 5.21M | 5.76M | 10.34M | 16.01M | 68.64M | 19.09M | 5.58M | 7.79M | 2.75M | 1.65M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | -3.72M | 0 | 0 | 0 | 0 |
Total operating expenses | 9.71M | 11.06M | 34.82M | -2.28M | 78.35M | 20.46M | 6.79M | 11.9M | 2.90M | 2.08M |
Operating income | -9.71M | -11.06M | -34.82M | 2.28M | -78.35M | -20.46M | -6.79M | -11.9M | -2.90M | -2.08M |
Other income (expenses), net | 3.21M | 5.26M | 5.71M | -3.66M | -15.77M | 2.83M | -3.13M | 2.66M | 283.33K | 97.01K |
Income before tax | -6.5M | -5.79M | -39.97M | -1.38M | -109.19M | -23.29M | -9.92M | -9.18M | -2.61M | -1.99M |
Income tax expense | 0 | 0 | 10.83M | 0 | 14.91M | 6.18M | 0 | -55K | 0 | 0 |
Net income | -6.5M | -5.79M | -39.97M | -1.38M | -109.19M | -23.29M | -9.92M | -9.18M | -2.61M | -1.99M |
Earnings per share | ||||||||||
Basic EPS | -16.64 | -3.07 | -28.32 | -12.51 | -133.71 | -35.64 | -197.58 | -27.19 | -99.22 | -146.8 |
Diluted EPS | -16.64 | -3.07 | -28.32 | -12.51 | -133.71 | -35.64 | -197.58 | -27.19 | -99.22 | -146.8 |